Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giedre Krenciute

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
Cell Reports. Medicine|May 5, 2021
Hypoxia-inducible CAR expression: An answer to the on-target/off-tumor dilemma?Brooke Prinzing, Giedre Krenciute
International Journal of Molecular Sciences|January 11, 2024
The Mechanisms of Altered Blood-Brain Barrier Permeability in CD19 CAR T-Cell RecipientsSoniya N Pinto, Giedre Krenciute
Frontiers in Oncology|March 14, 2019
Next Generation CAR T Cells for the Immunotherapy of High-Grade GliomaChristopher T Petersen, Giedre Krenciute
Cell Reports. Medicine|June 21, 2023
Steering CAR T cell epigenetic programs by tweaking manufacturing protocolMeghan W Dukes, Giedre Krenciute
Cell|June 13, 2025
The neurological toll of CAR T cell therapyMeghan B Ward, Giedre Krenciute
Cell Reports. Medicine|February 18, 2026
Cell therapy for brain tumors: The first 60 yearsSanya Mehta, Giedre Krenciute, Stephen Gottschalk
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|September 21, 2018
The Landscape of CAR T Cells Beyond Acute Lymphoblastic Leukemia for Pediatric Solid TumorsChristopher DeRenzo, Giedre Krenciute, Stephen Gottschalk
Frontiers in Oncology|November 11, 2021
T-Cell Immunotherapy for Pediatric High-Grade Gliomas: New Insights to Overcoming Therapeutic ChallengesDalia Haydar, Jorge Ibañez-Vega, Giedre Krenciute
Pharmacological Reviews|October 7, 2024
Therapeutic advantage of combinatorial CAR T cell and chemo-therapiesMeghan B Ward, Amber B Jones, Giedre Krenciute
Expert Review of Anticancer Therapy|March 14, 2018
CAR T-cell therapy for glioblastoma: ready for the next round of clinical testing?Brooke L Prinzing, Stephen M Gottschalk, Giedre Krenciute
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Cell Reports. Medicine|May 5, 2021
Hypoxia-inducible CAR expression: An answer to the on-target/off-tumor dilemma?Brooke Prinzing, Giedre Krenciute
International Journal of Molecular Sciences|January 11, 2024
The Mechanisms of Altered Blood-Brain Barrier Permeability in CD19 CAR T-Cell RecipientsSoniya N Pinto, Giedre Krenciute
Frontiers in Oncology|March 14, 2019
Next Generation CAR T Cells for the Immunotherapy of High-Grade GliomaChristopher T Petersen, Giedre Krenciute
Cell Reports. Medicine|June 21, 2023
Steering CAR T cell epigenetic programs by tweaking manufacturing protocolMeghan W Dukes, Giedre Krenciute
Cell|June 13, 2025
The neurological toll of CAR T cell therapyMeghan B Ward, Giedre Krenciute
Cell Reports. Medicine|February 18, 2026
Cell therapy for brain tumors: The first 60 yearsSanya Mehta, Giedre Krenciute, Stephen Gottschalk
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|September 21, 2018
The Landscape of CAR T Cells Beyond Acute Lymphoblastic Leukemia for Pediatric Solid TumorsChristopher DeRenzo, Giedre Krenciute, Stephen Gottschalk
Frontiers in Oncology|November 11, 2021
T-Cell Immunotherapy for Pediatric High-Grade Gliomas: New Insights to Overcoming Therapeutic ChallengesDalia Haydar, Jorge Ibañez-Vega, Giedre Krenciute
Pharmacological Reviews|October 7, 2024
Therapeutic advantage of combinatorial CAR T cell and chemo-therapiesMeghan B Ward, Amber B Jones, Giedre Krenciute
Expert Review of Anticancer Therapy|March 14, 2018
CAR T-cell therapy for glioblastoma: ready for the next round of clinical testing?Brooke L Prinzing, Stephen M Gottschalk, Giedre Krenciute
Pageof 6